Aviva’s private health cover sales jump 25% as NHS struggles with backlog
UK insurer Aviva reported a jump in sales of its private medical cover on Wednesday, as new data also showed patients have turned to private healthcare in record numbers while the NHS struggles with waiting times.
In a trading update, the FTSE 100 insurance company said its private healthcare sales rose 25 per cent to £33mn in the first quarter of the year as the NHS backlog encouraged more people to go private.
“Whilst the NHS does a great job for millions of people, there are people who would like to accelerate their treatment, or give themselves that confidence that should something happen to them, they want to have that accelerated treatment,” Aviva’s chief executive Amanda Blanc told the Financial Times. “The volumes are very robust and to be honest we don’t see that changing any time soon.”
This story originally appeared on: Financial Times - Author:Yasemin Craggs Mersinoglu